SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-000845
Filing Date
2023-05-09
Accepted
2023-05-09 16:31:12
Documents
43
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4668_10-q.htm   iXBRL 10-Q 634458
2 EXHIBIT 31.1 e4668_ex31-1.htm EX-31.1 8038
3 EXHIBIT 31.2 e4668_ex31-2.htm EX-31.2 7951
4 EXHIBIT 32.1 e4668_ex32-1.htm EX-32.1 5922
5 GRAPHIC img_001.jpg GRAPHIC 42091
6 GRAPHIC img_002.jpg GRAPHIC 28316
  Complete submission text file 0001731122-23-000845.txt   3080750

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20230331.xsd EX-101.SCH 26135
8 XBRL CALCULATION FILE avxl-20230331_cal.xml EX-101.CAL 26593
9 XBRL DEFINITION FILE avxl-20230331_def.xml EX-101.DEF 84416
10 XBRL LABEL FILE avxl-20230331_lab.xml EX-101.LAB 206309
11 XBRL PRESENTATION FILE avxl-20230331_pre.xml EX-101.PRE 155292
37 EXTRACTED XBRL INSTANCE DOCUMENT e4668_10-q_htm.xml XML 395760
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 23902635
SIC: 2836 Biological Products, (No Diagnostic Substances)